Bavarian Nordic on vaccine candidate: Preclinical data indicates broad protection

Preclinical data on Bavarian Nordic's covid-19 vaccine candidate indicates broad protection, the company reports on Thursday.
Photo: Philip Davali/Ekstra Bladet, Philip Davali
Photo: Philip Davali/Ekstra Bladet, Philip Davali
BY CHRISTOPHER DUE KARLSSON, TRANSLATED BY NIELSINE NIELSEN

In a press release on Thursday morning, Danish biotech company Bavarian Nordic states that new preclinical trial data indicates that the firm's vaccine candidate against covid-19 also has the ability to induce a high number of neutralizing antibodies against covid variants and mutations.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading